Today's deal net contains news from RAW Labs, Neuropain Therapeutics and Swajal.
RAW Labs, a Switzerland-based data management platform spun out of École Polytechnique Fédérale de Lausanne (EPFL), has closed a $5.5m pre-series A round backed by Investiere and undisclosed backers. The company announced Lars Farnstrom as its chief executive in conjunction with the round, while Claude Honegger and Pyrros Koussios will join the board of directors.
Neuropain Therapeutics, a France-based biotech developer focused on inflammatory and neuropathic pain, has raised €2.5m ($3m) in a round backed by private investors, according to Les Echos. Neuropain was spun out of Developmental Biology Institute of Marseille by French regional tech transfer office Satt Sud-Est late last year. The spinout is developing an analgesic to reduce post-surgery pain. It will look to raise an additional funding round before entering clinical trials in 2023.
Swajal, an India-based water purification technology developer founded by staff at Indian Institute of Technology Kanpur, has secured $1.6m in pre-series A funding from Rajasthan Asset Management Company and angel investors including Pramod Agarwal. The company had raised $1.2m from investors including solar engineering firm Saurya EnerTech and Abhishek Gupta in 2015.
